By Dan Gray
On Aug. 20, 2011, Marc Andreessen published the definitive manifesto for a generation of technologists and investors, with “Why Software Is Eating...
It’s been 6 months since we launched supplychaingamechanger.com. Our goal has always been to share experiences and expertise. The site has evolved. The number...
Symbols hold power – to bring tribes together, spark movements or flip scripts. The cannabis leaf shows this; beyond botany, it instantly signals counterculture...
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D. & Chan, W. C. W. Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J. Control....
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural...
Enjoying our podcasts? Don’t miss out on future episodes! Please hit that subscribe button on Apple, Spotify, YouTube, or your favorite podcast platform to stay updated with our...
Discussions on current European legislative initiatives edge forward in drug approval and the use of health data, and the potential for exploiting real-world evidence...
TOKYO and CAMBRIDGE, Mass., Sept 25, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated...
Apellis Pharmaceuticals has been slowly rebounding from an unjustified safety scare related to its approved treatment for a common type of vision loss. Now,...
Oberweis, C. V., Marchal, J. A., López-Ruiz, E. & Gálvez-Martín, P. A worldwide overview of regulatory frameworks for tissue-based products. Tissue Eng. B 26,...
Iveric Bio’s marketing authorisation application (MAA) for avacincaptad pegol (ACP) to treat a leading cause of blindness has been accepted for review by the...
